{
  "docId": "019de077-5130-7668-92cb-6c77396e6bd2",
  "docSlug": "e021a2de9332664c5094197b4bc248cd",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 157 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 108,
  "pageCount": 132,
  "prevPage": 107,
  "nextPage": 109,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 2,
  "notes": "The slide is part of an appendix, providing specific trial data for a drug candidate.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-5130-7668-92cb-6c77396e6bd2/108",
  "deckHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2",
  "deckJsonHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2.json",
  "deckAnchorHref": "/decks/019de077-5130-7668-92cb-6c77396e6bd2#slide-108",
  "components": [
    {
      "bbox": {
        "h": 1,
        "w": 0.03,
        "x": 0.97,
        "y": 0
      },
      "kind": "other",
      "text": "Oncology, CVRM, R&I, Other, V&I, Rare Disease",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "250f97ad-40bb-47d7-81d7-963f93fb8553",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.93,
        "x": 0.035,
        "y": 0.185
      },
      "kind": "table",
      "text": "Trial: Phase I NCT06138795; Population: Healthy volunteers; Patients: 104; Design: Randomised, placebo-controlled SAD/MAD trial; Endpoints: Primary endpoints: safety and tolerability; Status: FPCD: Q4 2023, Data anticipated: H1 2025",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d329154-1e38-4ca2-9586-9878d3779d03",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.54,
        "x": 0.035,
        "y": 0.045
      },
      "kind": "title",
      "text": "AZD2389 (anti-fibrotic mechanism)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cac030ec-1c30-4fee-8f83-2db7141d5925",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.11,
        "x": 0.035,
        "y": 0.115
      },
      "kind": "title",
      "text": "MASH",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb2ac678-aaef-4dfe-9527-3400acea2cf0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "f9fed5b3-c0fc-4bb3-998e-608a10f34e26",
      "evidence": "table/data: Trial: Phase I NCT06138795; Population: Healthy volunteers; Patients: 104; Design: Randomised, placebo-controlled SAD/MAD trial; Endpoints: Primary endpoints: safety and tolerability; Status: FPCD: Q4 2023, D",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 120,
      "from": 6,
      "beatId": "0c127c3c-ea10-450c-b057-64b7f7a0f03c",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Detailed overview of AstraZeneca's pipeline and portfolio",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}